Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1097/BOR.0000000000000217 http://scihub22266oqcxt.onion/10.1097/BOR.0000000000000217 C4639394!4639394!26352735     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=26352735&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215 Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\26352735.jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117       Curr+Opin+Rheumatol 2015 ; 27 (6): 555-62 Nephropedia Template TP {{tp|p=26352735|t=2015. Origin of Fibrosing Cells in Systemic Sclerosis |pdf=|usr=}}{{26352735}} gab.com Text Origin of Fibrosing Cells in Systemic Sclerosis JO: Curr Opin Rheumatol http://www.kidney.de/pget.php?&tw=1&pmid=26352735 #FOAvip Purpose of review: Systemic sclerosis (SSc), an autoimmune disease of unknown origin, is characterized by progressive fibrosis that can affect all organs of the body. To date, there are no effective therapies for the disease. This paucity of treatment options is primarily due to limited understanding of the processes that initiate and promote fibrosis in general and a lack of animal models that specifically emulate the chronic nature of systemic sclerosis. Most models capitulate acute injury-induced fibrosis in specific organs. Regardless of the model however, a major outstanding question in the field is the cellular origin of fibrosing cells. Recent findings: A multitude of origins have been proposed in a variety of tissues, including resident tissue stroma, fibrocytes, pericytes, adipocytes, epithelial cells, and endothelial cells. Developmentally derived fibroblast lineages have recently been elucidated with fibrosing potential in injury models. Increasing data supports the pericyte as a fibrosing cell origin in diverse fibrosis models and adipocytes have recently been proposed. Fibrocytes, epithelial cells, and endothelial cells have been examined, though data does not as strongly support these possible origins. Summary: In this review, we discuss recent evidence arguing in favor of and against proposed origins of fibrosing cells in diverse models of fibrosis. We highlight outstanding controversies and propose how future research may elucidate how fibrosing cells arise and what processes can be targeted in order to treat systemic sclerosis. Twit Text FOAVip Origin of Fibrosing Cells in Systemic Sclerosis ????Curr Opin Rheumatol http://www.kidney.de/pget.php?&tw=1&pmid=26352735 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=26352735 #FOAvip English Wikipedia <ref>{{Cite pmid|26352735}}</ref> Origin of Fibrosing Cells in Systemic Sclerosis #MMPMID26352735 Ebmeier S; Horsley V Curr Opin Rheumatol 2015[Nov]; 27 (6): 555-62 PMID26352735show ga Purpose of review: Systemic sclerosis (SSc), an autoimmune disease of unknown origin, is characterized by progressive fibrosis that can affect all organs of the body. To date, there are no effective therapies for the disease. This paucity of treatment options is primarily due to limited understanding of the processes that initiate and promote fibrosis in general and a lack of animal models that specifically emulate the chronic nature of systemic sclerosis. Most models capitulate acute injury-induced fibrosis in specific organs. Regardless of the model however, a major outstanding question in the field is the cellular origin of fibrosing cells. Recent findings: A multitude of origins have been proposed in a variety of tissues, including resident tissue stroma, fibrocytes, pericytes, adipocytes, epithelial cells, and endothelial cells. Developmentally derived fibroblast lineages have recently been elucidated with fibrosing potential in injury models. Increasing data supports the pericyte as a fibrosing cell origin in diverse fibrosis models and adipocytes have recently been proposed. Fibrocytes, epithelial cells, and endothelial cells have been examined, though data does not as strongly support these possible origins. Summary: In this review, we discuss recent evidence arguing in favor of and against proposed origins of fibrosing cells in diverse models of fibrosis. We highlight outstanding controversies and propose how future research may elucidate how fibrosing cells arise and what processes can be targeted in order to treat systemic sclerosis. äOrigin of Fibrosing Cells in Systemic Sclerosis (epmc).pdf DeepDyve Pubget Overpricing